Mudde; Geert
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mudde; Geert.The latest application filed is for "coiled-coil connector".
- Mudde; Geert - Breitenfurt AT
- Mudde; Geert - Breitenfurt bei Wien AT
- Mudde; Geert - Vienna AT
- Mudde; Geert - Wien AT
| Patent | Date |
|---|---|
| Her2/neu immunogenic composition Grant 11,154,599 - Mudde , et al. October 26, 2 | 2021-10-26 |
| Coiled-coil connector Grant 11,090,381 - Mudde , et al. August 17, 2 | 2021-08-17 |
| Immunoregulatory vaccine Grant 10,434,170 - Mudde O | 2019-10-08 |
| Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies Grant 10,189,905 - Mudde , et al. Ja | 2019-01-29 |
| Cytotoxic immunoglobulin Grant 10,125,197 - Himmler , et al. November 13, 2 | 2018-11-13 |
| Coiled-coil Connector App 20180236065 - MUDDE; Geert ; et al. | 2018-08-23 |
| Her2/neu Immunogenic Composition App 20180125953 - Mudde; Geert ; et al. | 2018-05-10 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170334992 - Mudde; Geert ; et al. | 2017-11-23 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170320942 - Mudde; Geert ; et al. | 2017-11-09 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20170320943 - Mudde; Geert ; et al. | 2017-11-09 |
| Display Of Binding Agents App 20170247432 - HIMMLER; Gottfried ; et al. | 2017-08-31 |
| Display of binding agents Grant 9,651,559 - Himmler , et al. May 16, 2 | 2017-05-16 |
| Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies Grant 9,636,415 - Mudde , et al. May 2, 2 | 2017-05-02 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20160362491 - Mudde; Geert ; et al. | 2016-12-15 |
| Cytotoxic Immunoglobulin App 20160176984 - Himmler; Gottfried ; et al. | 2016-06-23 |
| Gastrin Peptide Immunogenic Composition App 20160129096 - Mudde; Geert | 2016-05-12 |
| Cytotoxic immunoglobulin Grant 9,255,149 - Himmler , et al. February 9, 2 | 2016-02-09 |
| Immunoregulatory Vaccine App 20150196636 - Mudde; Geert | 2015-07-16 |
| Cytotoxic Immunoglobulin App 20150166665 - Himmler; Gottfried ; et al. | 2015-06-18 |
| Display Of Binding Agents App 20150153359 - HIMMLER; Gottfried ; et al. | 2015-06-04 |
| Display of binding agents Grant 8,921,279 - Himmler , et al. December 30, 2 | 2014-12-30 |
| Cytotoxic Immunoglobulin App 20140364592 - Himmler; Gottfried ; et al. | 2014-12-11 |
| Cytotoxic immunoglobulin Grant 8,859,738 - Himmler , et al. October 14, 2 | 2014-10-14 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20130243767 - Mudde; Geert ; et al. | 2013-09-19 |
| Cytotoxic Immunoglobulin App 20110046355 - Himmler; Gottfried ; et al. | 2011-02-24 |
| Display of Binding Agents App 20100184615 - Himmler; Gottfried ; et al. | 2010-07-22 |
| Bispecific Molecule Binding Tlr9 And Cd32 And Comprising A T Cell Epitope For Treatment Of Allergies App 20100143342 - Mudde; Geert ; et al. | 2010-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 